Literature DB >> 16527920

Skeletal muscle dysfunction in chronic renal failure: effects of exercise.

Gregory R Adams1, Nosratola D Vaziri.   

Abstract

A number of chronic illnesses such as renal failure (CRF), obstructive pulmonary disease, and congestive heart failure result in a significant decrease in exercise tolerance. There is an increasing awareness that prescribed exercise, designed to restore some level of physical performance and quality of life, can be beneficial in these conditions. In CRF patients, muscle function can be affected by a number of direct and indirect mechanisms caused by renal disease as well as various treatment modalities. The aims of this review are twofold: first, to briefly discuss the mechanisms by which CRF negatively impacts skeletal muscle and, therefore, exercise capacity, and, second, to discuss the available data on the effects of programmed exercise on muscle function, exercise capacity, and various other parameters in CRF.

Entities:  

Mesh:

Year:  2006        PMID: 16527920     DOI: 10.1152/ajprenal.00296.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  33 in total

Review 1.  Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.

Authors:  Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini
Journal:  Ageing Res Rev       Date:  2010-05-14       Impact factor: 10.895

Review 2.  Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure.

Authors:  Holly R Middlekauff
Journal:  Circ Heart Fail       Date:  2010-07       Impact factor: 8.790

Review 3.  Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Clin Exp Nephrol       Date:  2013-08-24       Impact factor: 2.801

4.  Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients.

Authors:  Michael I Lewis; Mario Fournier; Huiyuan Wang; Thomas W Storer; Richard Casaburi; Arthur H Cohen; Joel D Kopple
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

5.  Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score.

Authors:  Hemal A Bhatt; Dharmesh R Sanghani; David Lee; Kell N Julliard; George A Fernaine
Journal:  Int J Angiol       Date:  2015-03-23

6.  Functional responses of uremic single skeletal muscle fibers to redox imbalances.

Authors:  G I Mitrou; K P Poulianiti; Y Koutedakis; A Z Jamurtas; M D Maridaki; I Stefanidis; G K Sakkas; C Karatzaferi
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

7.  Effect of Chronic Kidney Disease and Supplemental Polyunsaturated Fatty Acid Use on Exercise Levels During Cardiac Rehabilitation in Patients With Coronary Artery Disease.

Authors:  Adam Pflum; Pallavi Gomadam; Hardik Mehta; Matthew Sacrinty; Connie C Paladenech; Killian Robinson
Journal:  J Cardiopulm Rehabil Prev       Date:  2017-05       Impact factor: 2.081

8.  Pulmonary hypertension in end-stage renal disease and post renal transplantation patients.

Authors:  Esam H Alhamad; Mohammed Al-Ghonaim; Hussam F Alfaleh; Joseph P Cal; Nazmi Said
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

9.  Impact of continuous positive airway pressure (CPAP) on the respiratory capacity of chronic kidney disease patients under hemodialysis treatment.

Authors:  Vivian Bertoni Xavier; Renata Spósito Roxo; Luiz Antônio Miorin; Vera Lúcia Dos Santos Alves; Yvoty Alves Dos Santos Sens
Journal:  Int Urol Nephrol       Date:  2015-04-30       Impact factor: 2.370

10.  Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility.

Authors:  Keith G Avin; Julian A Vallejo; Neal X Chen; Kun Wang; Chad D Touchberry; Marco Brotto; Sarah L Dallas; Sharon M Moe; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-20       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.